产品编号:H294460
产品规格:250mg
产品价格:面议
| 标准品编号: | H294460 |
| 名称: | [1,1'-Biphenyl]-4-carboxylic Acid (3aR,4R,5R,6aS)-Hexahydro-2-oxo-4-[(1E)-3-oxo-5-phenyl-1-penten-1-yl]-2H-cyclopenta[b]furan-5-yl ester |
| 别名: | [3aR-[3aα,4α(E),5β,6aα]]-[1,1'-Biphenyl]-4-carboxylic Acid Hexahydro-2-oxo-4-(3-oxo-5-phenyl-1-pentenyl)-2H-cyclopenta[b]furan-5-yl Ester; [1,1'-Biphenyl]-4-carboxylic Acid (3aR,4R,5R,6aS)-Hexahydro-2-oxo-4-[(1E)-3-oxo-5-phenyl-1-pentenyl]-2H-cyclopenta[b]furan-5-yl Ester |
| CAS号: | 41639-72-9 |
| 分子式: | C₃₁H₂₈O₅ |
| 外观: | 白色固体 |
| 分子量: | 480.55 |
| 溶解度: | DCM, Ethyl Acetate |
| 种类: | Building Blocks; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | [1,1'-Biphenyl]-4-carboxylic Acid (3aR,4R,5R,6aS)-Hexahydro-2-oxo-4-[(1E)-3-oxo-5-phenyl-1-penten-1-yl]-2H-cyclopenta[b]furan-5-yl ester is an intermediate in the synthesis of Latanoprost (L177280) related analogues used in the treatment of glaucoma and various degenerative eye diseases. |
| 参考文献 | |